A five-partner European consortium coordinated by Portuguese researchers from the Instituto de Medicina Molecular (IMM) in Lisbon will perform the industrial development of a novel pharmaceutical drug. This novel drug has analgesic properties and has potential therapeutic application in the fight against neurodegenerative diseases such as Alzheimer’s or Parkinson’s diseases.
The compound (BLV200704) was conceived by Miguel Castanho’s research team, who is an IMM researcher, and was then licensed to the biotech company BIOALVO, which collaborated in subsequent stages of development of the drug.
The first steps of the research that lead to the development of BLV200704 resulted from collaboration between Miguel Castanho’s and Isaura Tavares’ research teams (IMM and Faculdade de Medicina/IBMC, Oporto University, Portugal, respectively) and counted on BIOALVO partnership in a latter stage of development.
The industrial development of the drug by a consortium of the Portuguese teams – IMM and BIOALVO - and two other from Spain and Germany is now approved by Marie-Curie IAPP Action (Industry-Academia Partnerships and Pathways – IAPP **), will involve approximately 600.000,00 Euros and is coordinated by Miguel Castanho at IMM, Lisbon.
The project, called PEP2BRAIN, will consolidate the pharmacological development of BLV200704 and its potential derivatives.
This is the first Portuguese partnership successfully approved by the demanding and highly competitive IAPP Marie-Curie Action from the European Seventh Framework Programme (FP-7). Marie-Curie Actions from the FP-7 “People” Programme, and in particular IAPP, seek the support of innovative partnerships between public research centers and private institutions, namely small and medium enterprises, which have the ultimate goal of developing novel products and solutions.
“The EU approval of this project shows the emergence of an economy of innovation in Portugal and reflects the growth of scientific knowledge and a novel attitude of Portuguese researchers”, says Miguel Castanho, researcher at IMM and coordinator of the present consortium. “In our specific case, the partnership with industry, namely with BIOALVO, has been highly productive and reveals the potential to develop novel products capable of contributing to the enhancement of the life standards, especially of those who suffer from disease. This potential has been recognized by the panel of experts that recommended the approval of our application to EU’s IAPP Action.”
Patrícia Calado, BIOALVO’s Drug Discovery and Development Director, said: “It is very rewarding for BIOALVO to be the first Portuguese company to successfully accomplish the evaluation step of an FP7 IAPP proposal. The achievement of this milestone reinforces the value of establishing high quality partnerships between industry and academia. The work developed in collaboration with the group of Prof. Miguel Castanho is a combined effort acknowledged by the European Commission as a high-quality translational research program which is now successfully moving into advanced phases of drug development”.
* Members of the consortium: Instituto de Medicina Molecular (Portugal), BIOALVO SA (Portugal), University of Girona (Spain), Synovo GmbH (Germany) and University Eberhard Karls, Tübingen (Germany).
Marta Agostinho | alfa
Scientists uncover the role of a protein in production & survival of myelin-forming cells
19.07.2018 | Advanced Science Research Center, GC/CUNY
NYSCF researchers develop novel bioengineering technique for personalized bone grafts
18.07.2018 | New York Stem Cell Foundation
A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.
The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...
For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.
To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...
For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.
Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...
Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.
A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...
Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.
"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....
13.07.2018 | Event News
12.07.2018 | Event News
03.07.2018 | Event News
20.07.2018 | Power and Electrical Engineering
20.07.2018 | Information Technology
20.07.2018 | Materials Sciences